Latest - Public Health & Prevention
- Positive Topline Results for Antihypertensive Zilebesiran
- Sep 08 2023 This Week in Cardiology
- Liver Cancer Causes Differ Markedly by Race/Ethnicity
- Is Complete Revascularization Now Compulsory?
- Blood Test for Severe Preeclampsia Will Save Lives
- Pfizer, Valneva Say 'Positive' Result for Lyme Disease Vaccine
- Hepatitis C Virus Clearance Cascade, U.S. 2013-2022
- The PhenX Toolkit: Resource for Cancer Survivorship Research
- Histologic Analysis and Diagnostic Yield of Breast SCNB
- Efficacy, Durability, Tolerability of BIC/FTC/TAF for HIV
- Early Empiric Antibiotics in Hospitalized COVID-19 Patients
- 20 Best Places for Doctors to Retire: 2023
- How Do You Prescribe Exercise in Primary Prevention?
- Left-Digit Bias and Other Random Acts of Medicine
- Infographic: Doctors Act Out on Social Media, Peers See It
- Change Makers: Elcin Barker Ergun on Healthcare Renaissance
- Episode 6: RSV in Rural Communities: Lessons From Appalachia
- Online CBT Aids Remission of Anxiety, Depression in Students
- S2 Episode 6: Neoadjuvant Therapy and Renal Cell Carcinoma
- Episode 10: Approach to Cardiotoxicity: Art That Needs More Science
- Unclaimed Dead: Rising Number Used in Medical Schools
- Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes
- Gaps in Breast Cancer Receptor Testing for Certain Groups
- Artificial Intelligence Gives Paralyzed Woman Voice Back
- As MOC Debate Heats Up, Cardiology Societies Weigh In
- Mortality Rates Remain High After Hepatitis C Cure
- Artificial Sweeteners Increase Cardiovascular Risk
- Most With Early AD Not Eligible for New Anti-Amyloid Drugs
- Two Thirds Say They or Family Affected by Substance Use
- It May Be Time to Pay Attention to COVID Again
- A1c Not Linked to Postop Complications in Kids With Diabetes
- Social Needs Case Management Cuts Acute Care Usage
- Chickenpox to Blame for £24 Million Lost Yearly in Income and Productivity
- Only 1 in 4 Feel Fully Recovered Following COVID-19 Hospitalisation
- Patient Identified Who Battled COVID for 505 Days
- Cardiovascular Risk Linked with Severe COVID Risk
- Over-40s Called for Covid-19 Booster in Bid to Save Christmas
- Call for Tighter LDL Targets for Highest Risk Patients
- HIV Glasgow 2020